AUBH2013 REGISTRATION

Home

APHCON Executive Committee

Preceptorship Program

APHCON Mentors

Education

Clinical Trial Network

Treatment Guidelines

Membership Services

Online Library

Newsroom

AP SUMMIT

APHCON PRACTICE GUIDELINES: Chronic Myelogenous Leukemia
SHANGHAI, CHINA
JULY 5, 2013

CML WORKING GROUP

MEETING AGENDA
OBJECTIVE: Discuss and establish consensus guidelines for the diagnosis and practice of chronic myelogenous leukemia in APAC region
Opening Remarks: Dr. Xiao Jun Huang (APHCON President)
Presentation of data from prior meetings and publications: Simrit Parmar
Moderator: Simrit Parmar
Discussion points:
1.     Diagnostic essentials for CML.
Specifically discuss
-            Role of FISH vs. Cytogenetics vs. PCR: Cost effectiveness and usability in clinical decision making
-            Role of Bone Marrow Biopsy: diagnosis and monitoring
-            Can peripheral blood diagnostics be sufficient for monitoring?
-            Mutation analysis. Timing and benefit?
2.     Definition of treatment response
3.     Definition of progression
4.     Decision making tree for treatment options for progression
5.     Management of side effects of therapeutics and dose adjustment guidelines

DISCUSSION PANEL
Jiong Hu                                     Surapol Issaragrisil                  JianXiang Wang
Guiseppe Saglio                          Yeow Tee Goh                         Zhi Xiang Shen                                                    Raymond Wong                            Andreas Hochhaus                Xiao Jun Huang
Simrit Parmar                                Qian Jiang

Summary of the Discussion: Simrit Parmar
Closing Comments and timeline to publication: Xiao Jun Huang